TD Cowen analyst Gary Taylor raised the firm’s price target on Alignment Healthcare (ALHC) to $18.50 from $17 and keeps a Buy rating on the shares. The firm updated its model following Q3 results as they raised their guidance for the fourth consecutive quarter since Q3 2024.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALHC:
- Alignment Healthcare’s Earnings Call Highlights Strong Growth
- Strong Buy Rating Backed by Consistent EBITDA Growth and Strategic Expansion
- Alignment Healthcare price target raised to $18 from $13 at Barclays
- Alignment Healthcare price target raised to $18 from $17 at UBS
- Alignment Healthcare Surpasses Q3 2025 Financial Expectations